Mosaic ImmunoEngineering Inc.
CPMV · OTC
12/31/2024 | 12/31/2022 | 12/31/2021 | 12/31/2020 | |
|---|---|---|---|---|
| Revenue | $0 | $0 | $0 | – |
| % Growth | – | – | – | – |
| Cost of Goods Sold | $0 | $0 | $0 | – |
| Gross Profit | $0 | $0 | $0 | – |
| % Margin | – | – | – | – |
| R&D Expenses | $184 | $1,048 | $1,456 | – |
| G&A Expenses | $696 | $1,579 | $2,045 | – |
| SG&A Expenses | $696 | $1,579 | $2,045 | – |
| Sales & Mktg Exp. | $0 | $0 | $0 | – |
| Other Operating Expenses | $0 | $0 | $0 | – |
| Operating Expenses | $880 | $2,628 | $3,501 | – |
| Operating Income | -$880 | -$2,628 | -$3,661 | – |
| % Margin | – | – | – | – |
| Other Income/Exp. Net | -$40 | $249 | -$21 | – |
| Pre-Tax Income | -$920 | -$2,378 | -$3,682 | – |
| Tax Expense | $2 | $2 | $2 | – |
| Net Income | -$922 | -$2,381 | -$3,684 | – |
| % Margin | – | – | – | – |
| EPS | -0.13 | -0.33 | -0.55 | – |
| % Growth | 60.6% | 40% | – | – |
| EPS Diluted | -0.13 | -0.33 | -0.55 | – |
| Weighted Avg Shares Out | 7,092 | 7,236 | 6,713 | – |
| Weighted Avg Shares Out Dil | 7,236 | 7,236 | 6,713 | – |
| Supplemental Information | – | – | – | – |
| Interest Income | $0 | $0 | $0 | – |
| Interest Expense | $80 | $70 | $30 | – |
| Depreciation & Amortization | $880 | $343 | $160 | – |
| EBITDA | -$838 | -$2,284 | -$3,501 | – |
| % Margin | – | – | – | – |